SCHEMBL12376807

SCHEMBL12376807

CCc1cc(-c2ccc(OC(F)(F)F)cc2)nn1Cc1ccc(C(=O)NCC(O)C(=O)O)cc1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GCGR P47871 19/20 0.72
▸ HDAC3 O15379 1/20 0.55
▸ HDAC4 P56524 1/20 0.55
▸ HDAC1 Q13547 1/20 0.55
▸ HDAC7 Q8WUI4 1/20 0.55
▸ HDAC2 Q92769 1/20 0.55
▸ HDAC10 Q969S8 1/20 0.55
▸ HDAC11 Q96DB2 1/20 0.55
▸ HDAC8 Q9BY41 1/20 0.55
▸ HDAC6 Q9UBN7 1/20 0.55
▸ HDAC9 Q9UKV0 1/20 0.55
▸ HDAC5 Q9UQL6 1/20 0.55
▸ NCOR2 Q9Y618 1/20 0.55
▸ GIPR P48546 4/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2C8 P10632 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ KCNH2 Q12809 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2667421 0.90 GCGR (0.89) GCGRGIPRCYP3A4CYP2C8CYP2C9
SCHEMBL12377002 0.86 GCGR (0.80) GCGRHDAC3HDAC4HDAC1HDAC7
SCHEMBL2667455 0.86 GCGR (0.94) GCGRGIPRCYP3A4CYP2C8CYP2C9
SCHEMBL12360212 0.85 GCGR (0.78) GCGRGIPRCYP3A4CYP2C8CYP2C9
SCHEMBL12360196 0.85 GCGR (0.78) GCGRGIPRCYP3A4CYP2C8CYP2C9
SCHEMBL2667332 0.84 GCGR (1.00) GCGRGIPRCYP3A4CYP2C8CYP2C9
SCHEMBL12360237 0.84 GCGR (0.71) GCGRGIPRCYP3A4CYP2C8CYP2C9
SCHEMBL2667302 0.83 GCGR (0.66) GCGRGIPRCYP3A4CYP2C8CYP2C9
SCHEMBL2667524 0.83 GCGR (0.78) GCGRGIPRCYP3A4CYP2C8CYP2C9
SCHEMBL2254559 0.83 GCGR (0.78) GCGRGIPRCYP3A4CYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989475-B2 Substituted pyrazoles, compositions containing such compounds and methods of use MERCK SHARP & DOHME CORP. (US) 2011-08-02 — — US disclosed
US-20090215825-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK SHARP & DOHME LLC 2009-08-27 — — US disclosed
US-7572922-B2 Substituted pyrazoles, compositions containing such compounds and methods of use MERCK & CO., INC. (US) 2009-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215825-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE GLP1R, GCGR, GPR119 GCGR 2/4885HDAC3 347/4885HDAC4 1382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback